Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices
NCT ID: NCT00811551
Last Updated: 2019-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2008-12-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study
NCT00500838
PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing
NCT00409916
Detect Fluid Early From Intra-thoracic Impedance Monitoring
NCT00916929
Evaluation of Left Ventricular AutoThreshold
NCT00812201
Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients
NCT01501331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CRT-D (Intra-thoracic Impedance Monitoring)
Diagnostic Feature in CRT-D device that emits a sub-threshold pulse to measure resistance between two electrodes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have the ability to provide written informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluation.
* Have legally marketed bipolar right atrial and true bipolar right ventricular pacing defibrillation leads, and a legally marketed endocardial bipolar LV lead.
Exclusion Criteria
* Have any medical condition that would interfere with intra-thoracic measurements such as end-stage pulmonary disease, advanced interstitial pulmonary disease, or frequent episodes of pneumonia.
* Have a contraindication for right heart catheterization.
* Have a contraindication for the delivery of IV Nitroglycerin.
* Be pregnant or planning a pregnancy for the duration of their study participation.
* Be currently participating in a clinical investigation that includes an active treatment arm.
* Have a life expectancy of less than 12 months due to any condition.
* Be unable to perform the Valsalva maneuver with airway pressure \> 40 mm Hg for ≥10 seconds.
* Are pacemaker dependent, where cessation of pacemaker function consistently results in syncope or ventricular asystole.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Carlson, MD
Role: STUDY_DIRECTOR
Abbott Medical Devices
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Little Rock Cardiology Clinic
Little Rock, Arkansas, United States
Huntington Memorial Hospital
Pasadena, California, United States
Colorado Springs Cardiology
Colorado Springs, Colorado, United States
The Emory Clinic - Crawford Long Hospital
Atlanta, Georgia, United States
Midwest Heart Research Foundation
Lombard, Illinois, United States
Lahey Clinic Medical Center
Burlington, Massachusetts, United States
St. Thomas Hospital Heart
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRD 440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.